Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00863 |
| Species: | Homo sapiens |
| Position : | chr13:42965000-42965891 |
| Year: | 2018 |
| Title: | Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer. |
| Genome Build: | hg19 |
| Enhancer Type: | Super-enhancer |
| Condition: | Disease |
| Disease Name: | osteoporosis |
| PMID: | 29528523 |
| MONDO: | MONDO:0005298 |
| Tissue: | bone marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | CD34+ hematopoietic stem/progenitor cells |
| Cell Type: | hematopoietic stem/progenitor cell |
| Experiment Type: | Risk-variant regulatory analysis; super-enhancer annotation; enhancer-gene interaction |
| High Throughput Method: | GWAS/eQTL; Hi-C; ChIP-seq/RNA-seq integration; eQTL analysis |
| Low Throughput Method: | Reporter/qRT-PCR/ChIP-qPCR validation for selected functional variants/constituents; CRISPR-Cas9; Luciferase reporter assay |
| Target gene : | TNFSF11 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00871 | chr13:42939000-42967000 | bone marrow | hematopoietic stem/progenitor cell | osteoporosis |
| E_00872 | chr13:42939000-42967000 | blood | B-lymphoblastoid cell | osteoporosis |
| E_00873 | chr13:42939000-42967000 | bone | osteosarcoma-derived osteoblast-like cell | osteoporosis |
| E_00864 | chr13:42965000-42965891 | blood | B-lymphoblastoid cell | osteoporosis |
| E_00867 | chr13:42965000-42965891 | bone | osteosarcoma-derived osteoblast-like cell | osteoporosis |